Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Apr 2019 for Guardion Health Sciences, Inc., €3,550.
Filing timeline
BuySaleMichael Favish
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael Favish: trading record in brief
Michael Favish discloses dealings in Guardion Health Sciences, Inc. to SEC (Form 4). We count 4 filings; the first trade dates from 31 December 2016 and the latest from 9 April 2019.
The open-market record is one-sided, with 1 purchase worth €389k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants.
The record was last updated on 10 April 2019 with a share grant (€3,550) in Guardion Health Sciences, Inc. The clock since the last published purchase (3 January 2017) now reads 3,581 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Favish
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
1,000 shares@ US$4.00100.0% of flowCommon StockSEC:0001144204-19-019054:0
50,000 shares0Common StockSEC:0001135337-17-000002:0
684,933 shares@ US$0.60Common StockSEC:0001135337-17-000002:1
Canonical exit: 31 Mar 2017 (T+90)
10,000 shares0Common StockSEC:0001135337-17-000002:2
4 of 4 declarations
